BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Link Technologies Ltd to Present Poster at Cambridge Symposium on Nucleic Acids


8/25/2011 10:44:28 AM

BELLSHILL, SCOTLAND, 25 August 2011: Link Technologies Ltd, an ISO 9001:2008 certified specialist oligonucleotide reagent manufacturer, will exhibit and present a poster at this year’s Cambridge Symposium on Nucleic Acids Chemistry and Biology (CSNACB), Cambridge, UK (4-7 September 2011). Entitled ‘Tocopherol (Vitamin E) Modified Oligonucleotides’, the new poster builds on previous findings generated by the scientists at Link Technologies and describes the use of the vitamin tocopherol to improve the purification of thiol-modified oligos. Thiol-modification is often used as a means of incorporating labels such as dyes and other active compounds directly into oligos, the likes of which have a range of applications such as in diagnostics research.

Link Technologies supplies reagents for oligo synthesis and modification, with a focus on quality, flexibility and responsiveness. An ISO 9001:2008 certified quality management system, rigorous quality control (QC) procedures and pro-active delivery tracking all help to maximise accuracy and efficiency. In stock items are shipped-same day and all enquiries are dealt with in less than 24hrs, while a fully bespoke custom synthesis service and flexible QC options complement the extensive product catalogue to rapidly and reliably meet the individual needs of each customer. To learn more about the solutions offered by Link Technologies visit the stand at CSNACB. Alternatively, follow @linktechdna on Twitter for all the latest news from the show and beyond. More information can also be found by reading the latest Link Technologies blog post.

About Link Technologies Ltd

Link Technologies Ltd is a leading kilo-scale supplier of speciality reagents for oligonucleotide synthesis and modification, all to the ISO 9001:2008 quality certification. The company’s main markets are university and commercial research departments, plus, increasingly, larger Contract Manufacturing Organisations (CMOs) in the biotech sector.

Link has also forged successful links to academia working closely with many UK universities. In tandem with internal research and development, the Company has an excellent record in bringing in-licence products to market with various worldwide commercial partners.

For further information see: www.linktech.co.uk.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES